Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
Open | $1.670 |
Close | $1.630 |
Volume / Avg. | 3.715M / 4.770M |
Day Range | 1.620 - 1.730 |
52 Wk Range | 0.920 - 3.789 |
Market Cap | $403.828M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 32 |
Short Interest | 45.92% |
Days to Cover | 5.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Humacyte (NASDAQ:HUMA), Voyager Therapeutics (NASDAQ:VYGR), Replimune Group (NASDAQ:REPL), PepGen (NASDAQ:PEPG) and CareDx (NASDAQ:CDNA).
The latest price target for Lexicon Pharmaceuticals (NASDAQ: LXRX) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 0.00 expecting LXRX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.64 last updated Today at April 18, 2024 at 6:42 PM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.